Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/1995
11/01/1995CN1110922A Navel medicine bag for treatment of indigestion and child digestive disorder and its prepn.
10/1995
10/31/1995US5463083 2,5-diaryl tetrahydrothiophenes, tetrahydrofurans and 1,3-diaryl-cyclopentanes which act as platelet activating factor receptor antagonists and/or inhibitors of the enzyme 5-lipoxygenase
10/31/1995US5463074 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
10/31/1995US5462945 N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
10/31/1995US5462933 Modified bile acid conjugates, and their use as pharmaceuticals
10/31/1995US5462924 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
10/30/1995CA2148053A1 Non-peptidyl tachykinin receptor antagonists
10/26/1995WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028418A2 Tachykinin antagonists
10/26/1995WO1995028399A1 A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
10/26/1995WO1995028391A1 Cck or gastrin modulating 1,5 benzodiazepines derivatives
10/26/1995WO1995028170A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2188287A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995CA2186872A1 Cck or gastrin modulating 1,5 benzodiazepines derivatives
10/26/1995CA2183991A1 Tachykinin antagonists
10/25/1995EP0678298A2 Use of 4-(2-formyl-3-hydroxyphenoxymethyl)benzoic acid as immopotentiatory agent
10/25/1995EP0678098A1 Pyrrolidine and thiazolidine derivatives, their preparation and drugs containing same
10/25/1995EP0678097A1 Novel colon- or ileum-specific steroid derivatives
10/25/1995EP0678089A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/25/1995EP0678088A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
10/24/1995US5461082 Dried aluminum hydroxide gel, a method for preparing the dried gel, and an antacid
10/24/1995US5461045 Treating thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer and hypertension
10/24/1995US5461033 Administering transforming growth factor-beta containing acid casein fraction isolated from bovine milk to treat crohn's disease
10/24/1995US5460810 Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
10/24/1995CA1337415C Indole derivatives
10/19/1995WO1995027781A1 Superoxide dismutase-4
10/19/1995WO1995027723A1 Receptor modulating agents and methods relating thereto
10/19/1995WO1995027496A1 Vasoactive intestinal polypeptide
10/19/1995WO1995027490A1 Use of serotonin antagonists (5ht3) for treating fibromyalgia
10/19/1995WO1995027486A1 Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion
10/19/1995WO1995027480A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995WO1995019433A3 Anti-hepatitis b poly- and oligonucleotides
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/19/1995CA2187651A1 Low dosage ranitidine compositions for the treatment of minor gastrointestinal disorders associated with excess acid secretion
10/19/1995CA2187635A1 Superoxide dismutase-4
10/19/1995CA2187322A1 Vasoactive intestinal polypeptide
10/19/1995CA2187312A1 Heme-bearing microparticles for targeted delivery of drugs
10/18/1995EP0677104A1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677059A1 Endothelin converting enzyme inhibitors
10/18/1995EP0677049A1 Quinazoline derivatives
10/18/1995EP0569393B1 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition
10/18/1995CN1110477A Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110151A Antialcoholic liver-protecting preparation and its preparing method
10/17/1995US5459152 Platelet activating factor antagonists
10/17/1995US5459142 Pyrazinyl and piperazinyl substituted pyrazine compounds
10/17/1995US5459135 Administer synergistic amounts of dedimethylaminotetracycline and indomethacin
10/17/1995CA1337347C Benzimidazoline-2-one-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995026960A1 Physiologically active substance ei-1507
10/12/1995WO1995026957A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
10/12/1995WO1995026737A1 Use of biopolymers for digestive tract injuries treatment
10/12/1995CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity
10/11/1995EP0676414A1 Lipases immobilized in sol-gel processed hydrophobic materials
10/11/1995EP0676411A2 Peptides and pseudopeptides derived from tachykinine, their preparation and their pharmaceutical compositions
10/11/1995EP0675893A1 Anticonvulsant sorbopyranose sulfamates
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675730A1 Therapeutic combination containing interferon
10/11/1995EP0675705A1 Oral compositions containing antiplaque, anticalculus agents
10/11/1995CN1029973C Substituted thiophenoimidazole derivatives, process for preparing same and pharmaceutical agent containing same and use as gastric acid secretive inhibitor
10/10/1995US5457101 Thieno[1,5]benzoidiazepine use
10/10/1995US5456925 Salt of ranitidine and complex of bismuth and tartaric or citric acid with alkaline salt; improved disintegration or dissolution
10/10/1995US5456918 Ranitidine pharmaceutical compositions
10/10/1995CA2049086C Microbiologically stabilized phase for bicarbonate toothpaste manufacture
10/10/1995CA1337297C Aminoacylates of glycerol acetal
10/10/1995CA1337272C Drug adsorbates
10/05/1995WO1995026360A1 Antagonists of endothelin receptors
10/05/1995WO1995026349A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
10/05/1995WO1995026186A1 Methods of administering n-substituted benzamides or phenothiazines
10/05/1995WO1995021611A3 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
10/05/1995CA2183767A1 Antagonists of endothelin receptors
10/05/1995CA2182952A1 Methods of administering n-substituted benzamides or phenothiazines
10/04/1995EP0675110A1 1H-Indole-3-glyoxylamide sPLA2 inhibitors
10/04/1995EP0674705A1 Antisense oligonucleotides to inhibit expression of mutated and wild type genes for collagen
10/04/1995EP0674642A1 Pyrazolopyrimidines as crf antagonists
10/04/1995EP0674641A1 Pyrrolopyrimidines as crf antagonists
10/04/1995EP0674639A1 Azanoradamantanes
10/04/1995EP0674628A1 New chemopreventive compounds and a preparation method and use thereof
10/04/1995EP0674625A1 Amino-substituted pyrazoles having crf antagonistic activity
10/04/1995EP0674624A1 Pyrazoles and pyrazolopyrimidines having crf antagonist activity
10/04/1995EP0618905B1 Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists
10/04/1995CN1109471A Derivative of imidazol-4yl-piperidine, preparation of same and application of same in treatment
10/03/1995US5455274 Leukotriene antagonists; treating rheumatoid arthritis
10/03/1995US5455273 N,N-disubstituted arylcycloalkylamines, the salts thereof, pharmaceutical compositions containing these compounds and the use thereof and processes for preparing them
10/03/1995US5455258 Useful as inhibitors of matrix-degrading metalloproteinase enzymes such as stromelysin and/or collegenase
10/03/1995US5455246 Treating neuropsychiatric disorders
10/03/1995CA1337199C Five-membered ring systems with bonded azacyclic ring substituents
10/03/1995CA1337197C Subtituted thienoimidazole derivatives, a process for their preparation, pharmaceutical compositions containing them, and their use as inhibitors of gastric acid secretion
10/03/1995CA1337193C Muscarinic receptor antagonists
09/1995
09/28/1995WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS
09/28/1995WO1995025721A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
09/28/1995DE4410822A1 Neue Piperidin-Derivate New piperidine derivatives
09/28/1995CA2186010A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
09/27/1995EP0673933A1 Aminoalkyl benzoxazolinones and benzothiazolinones process for their preparation and compositions containing them
09/27/1995EP0673932A1 Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-N-oxides, process for their preparation and their use as medicaments
09/27/1995EP0673928A1 Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists
09/27/1995EP0673646A2 Use of Deoxypergualin in the manufacture of a medicament for the treatment of inflammatory-hyperresponsiveness diseases
1 ... 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 ... 1258